Key facts
- Cercle’s last known valuation is $25.0M.
- It has raised $10.5M; the latest was Seed Round ($6.0M) in Sep 2024.
- Notable investors include FemHealth Ventures, Sheryl Sandberg, Sandberg Bernthal Venture Partners, CG Health Ventures, Outsiders Fund — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cercle
- ·The full record, as it builds
Funding rounds
No funding rounds for Cercle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cercle
Developer of an artificial intelligence-driven healthcare insights platform designed to enhance data utilization for women's healthcare providers. The company's platform analyzes anonymized data points securely drawn from hospitals, clinics, and research labs and turns unstructured and disconnected healthcare data points into clear insights, enabling doctors, hospitals, research centers, pharmaceutical companies, labs, and clinics to improve operational efficiency and deliver personalized care while navigating the complexities of health data management.
- Sector
- Healthcare
- HQ
- Frisco, TX, United States
- Founded
- 2020
- Employees
- 34
- Website
- cercle.ai/
- Ownership
- Privately Held (backing)
Cercle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cercle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cercle in its N-PORT filings yet. We sweep new filings monthly.